Empagliflozin Impurity 135

Synchemia is a leading supplier in pharmaceutical Empagliflozin Impurities . Empagliflozin (commonly known by the brand name Jardiance) is an SGLT2 inhibitor primarily used to manage Type 2 diabetes by lowering blood sugar through urine excretion. It is also prescribed to reduce cardiovascular death in diabetes patients, manage chronic heart failure, and reduce the risk of chronic kidney disease progression.

Empagliflozin Impurity 135 CAS NO: 2452301-06-1 chemically represented as (2R,3S,4S,5R)-2-(4-chloro-3-(4-(((S)-tetrahydrofuran-3-yl)oxy)benzyl)phenyl)-5-((R)-1,2-diacetoxyethyl)tetrahydrofuran-3,4-diyl diacetate . Empagliflozin Impurity 135 is supplied with comprehensive characterization data, in full compliance with applicable regulatory guidelines. Synchemia is the leading supplier and exporter of Empagliflozin Impurity 135 . All Synchemia products are strictly intended for analytical testing purposes only and not for human use.